BioCentury
ARTICLE | Clinical News

Chiron, MGI regulatory update

February 27, 1995 8:00 AM UTC

Chiron Corp. (CHIR) MGI Pharma Inc. (MOGN) MOGN's Salagen tablets (pilocarpine hydrochloride) received U.K. approval to treat symptoms associated with radiation-induced xerostomia (chronic dry mouth...